Endocrinol Metab.  2020 Jun;35(2):377-383. 10.3803/EnM.2020.35.2.377.

Consistency of the Glycation Gap with the Hemoglobin Glycation Index Derived from a Continuous Glucose Monitoring System

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Abstract

Background
Discordances between glycated hemoglobin (HbA1c) levels and glycemic control are common in clinical practice. We aimed to investigate the consistency of the glycation gap with the hemoglobin glycation index (HGI).
Methods
From 2016 to 2019, 36 patients with type 2 diabetes were enrolled. HbA1c, glycated albumin (GA), and fasting blood glucose levels were simultaneously measured and 72-hour continuous glucose monitoring (CGM) was performed on the same day. Repeated tests were performed at baseline and 1 month later, without changing patients’ diabetes management. The HGI was calculated as the difference between the measured HbA1c and the predicted HbA1c that was derived from CGM. The glycation gap was calculated as the difference between the measured and GA-based predicted HbA1c levels.
Results
Strong correlations were found between the mean blood glucose (MBG)-based HGI and the prebreakfast glucose-based HGI (r=0.867, P<0.001) and between the glycation gap and the MBG-based HGI (r=0.810, P<0.001). A close correlation was found between the MBG-based HGI at baseline and that after 1 month (r=0.729, P<0.001), with a y-intercept of 0 and a positive slope.
Conclusion
The HGI and glycation gap were highly reproducible, and the magnitudes of repeated determinations were closely correlated. Patients with similar mean glucose levels may have significantly different HbA1c levels.

Keyword

Glycosylation; Glycosylated hemoglobin A; Glycosylated serum albumin

Figure

  • Fig. 1 Correlations between parameters at baseline (first visit) and 1 month later (second visit). (A) Glycation gap at the first visit on the x-axis, against the glycation gap at the second visit on the y-axis (r=0.888, P<0.001). (B) Fasting blood glucose (FBG)-based hemoglobin glycation index (HGI) at the first visit on x-axis, against the FBG-based HGI at the second visit on the y-axis (r=0.691, P<0.001). (C) Mean blood glucose (MBG)-based HGI at the first visit on the x-axis, against the MBG-based HGI at the second visit on the y-axis (r=0.729, P<0.001). (D) Prebreakfast glucose-based HGI at the first visit on the x-axis, against the prebreakfast glucose-based HGI at the second visit on the y-axis (r=0.843, P<0.001). BG, blood glucose.


Reference

1. Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev. 2019; 40:988–99.
Article
2. Khera PK, Joiner CH, Carruthers A, Lindsell CJ, Smith EP, Franco RS, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes. 2008; 57:2445–52.
Article
3. Kim MK, Jeong JS, Kwon HS, Baek KH, Song KH. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes. J Diabetes Complications. 2017; 31:1127–31.
Article
4. Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015; 38:1067–74.
Article
5. Kim MK, Jeong JS, Yun JS, Kwon HS, Baek KH, Song KH, et al. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: a 10-year longitudinal cohort study. J Diabetes Complications. 2018; 32:906–10.
Article
6. Rhee EJ, Cho JH, Kwon H, Park SE, Park CY, Oh KW, et al. Association between coronary artery calcification and the hemoglobin glycation index: the Kangbuk Samsung Health Study. J Clin Endocrinol Metab. 2017; 102:4634–41.
Article
7. Ahn CH, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, et al. Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism. J Clin Endocrinol Metab. 2017; 102:2905–13.
Article
8. Riddle MC, Gerstein HC. Comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067–74. Diabetes Care. 2015; 38:e170–1.
9. Cohen RM, Snieder H, Lindsell CJ, Beyan H, Hawa MI, Blinko S, et al. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care. 2006; 29:1739–43.
Article
10. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care. 2003; 26:163–7.
Article
11. Kim MK, Yun KJ, Kwon HS, Baek KH, Song KH. Discordance in the levels of hemoglobin A1C and glycated albumin: calculation of the glycation gap based on glycated albumin level. J Diabetes Complications. 2016; 30:477–81.
Article
12. Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, et al. Results of a study comparing glycated albumin to other glycemic indices. J Clin Endocrinol Metab. 2020; 105:677–87.
Article
13. Lachin JM, Genuth S, Nathan DM, Rutledge BN. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial. Diabetes. 2007; 56:1913–21.
Article
14. Gonzalez A, Deng Y, Lane AN, Benkeser D, Cui X, Staimez LR, et al. Impact of mismatches in HbA1c vs glucose values on the diagnostic classification of diabetes and prediabetes. Diabet Med. 2020; 37:689–96.
15. Cohen RM, Franco RS, Smith EP, Higgins JM. When HbA1c and blood glucose do not match: how much is determined by race, by genetics, by differences in mean red blood cell age? J Clin Endocrinol Metab. 2019; 104:707–10.
Article
16. Dunmore SJ, Al-Derawi AS, Nayak AU, Narshi A, Nevill AM, Hellwig A, et al. Evidence that differences in fructosamine-3-kinase activity may be associated with the glycation gap in human diabetes. Diabetes. 2018; 67:131–6.
Article
17. Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med. 2017; 167:95–102.
Article
18. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008; 112:4284–91.
Article
19. Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, et al. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One. 2017; 12:e0175547.
Article
20. Yoo JH, Kang YM, Cho YK, Lee J, Jung CH, Park JY, et al. The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects. Clin Endocrinol (Oxf). 2019; 91:271–7.
Article
21. Liu S, Hempe JM, McCarter RJ, Li S, Fonseca VA. Association between inflammation and biological variation in hemoglobin A1c in U.S. nondiabetic adults. J Clin Endocrinol Metab. 2015; 100:2364–71.
Article
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr